Recital 21, Regulation (EU) 2026/2348

In force

The application for the renewal of the approval of the active substance 2,5-dichlorobenzoic acid methylester was submitted on 31 August 2016 and the rapporteur Member State informed the co-rapporteur Member State, the Commission and the Authority on 26 October 2016 that it had assessed the admissibility of the application pursuant to Article 3 of Implementing Regulation (EU) No 844/2012, and in particular its completeness and timeliness, and concluded that it was admissible. The application has been made public by the Authority. On 13 February 2024, the rapporteur Member State submitted the draft renewal assessment report to the Authority, which conducted a public consultation on it between 12 September and 11 November 2024. On 18 September 2025, the Authority requested additional information for the purposes of the renewal assessment pursuant to Article 13(3) of Implementing Regulation (EU) No 844/2012 and the applicant submitted that information on 24 October 2025 within the deadline given. On 30 March 2026, the rapporteur Member State submitted the revised draft renewal assessment report to the Authority. The Authority estimates that it will be able to finalise its conclusion for 2,5-dichlorobenzoic acid methylester around January 2027, and as the Commission will need time to adopt the ensuing risk management decisions, the duration of the extension of the approval period should be set at 17 months and 15 days, until 15 May 2028.

  • celex=32012R0844